PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26238339-11	2016	Irrespective of the dietary vitamin D3, dietary soy is able to increase tumour volume when tumours overexpress CYP24A1, suggesting that combination of vitamin D3 and soy could have an anti-tumourigenic effect only if CYP24A1 levels are normal.	Cholecalciferol	151-161	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	111-118	
29186386-4	2018	Mice supplemented with cholecalciferol (15,000 IU/kg of body weight per day) for 4 days showed decreased messenger RNA (mRNA) levels of proteins involved in cholecalciferol metabolism (Cyp24a1, Cyp27a1) and decreased cubilin mRNA levels in WAT.	Cholecalciferol	23-38	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	185-192	
29186386-4	2018	Mice supplemented with cholecalciferol (15,000 IU/kg of body weight per day) for 4 days showed decreased messenger RNA (mRNA) levels of proteins involved in cholecalciferol metabolism (Cyp24a1, Cyp27a1) and decreased cubilin mRNA levels in WAT.	Cholecalciferol	157-172	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	185-192	
28130182-8	2017	Treatment of BEC with 10muM cholecalciferol led to increases in both CYP24A1 and CFTR mRNA levels, even when added to the apical surface of cells grown in an air-liquid interface, suggesting that topical administration of vitamin D could be used therapeutically.	Cholecalciferol	28-43	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	69-76	
27018098-9	2016	Interestingly, both myoblasts and myotubes expressed CYP27B1 and CYP24 mRNA which are required for vitamin D3 metabolism.	Cholecalciferol	99-109	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	65-70	
26238339-11	2016	Irrespective of the dietary vitamin D3, dietary soy is able to increase tumour volume when tumours overexpress CYP24A1, suggesting that combination of vitamin D3 and soy could have an anti-tumourigenic effect only if CYP24A1 levels are normal.	Cholecalciferol	151-161	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	217-224	
24081904-7	2014	Remarkably, subcutaneous and orthotopic xenografts of prostate cancer cells harboring CYP24A1 shRNA resulted in a drastic reduction in tumor volume when mice were subjected to vitamin D3 supplementation.	Cholecalciferol	176-186	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	86-93	
18981260-0	2009	Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation.	Cholecalciferol	174-184	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	144-151	
7578252-0	1995	Molecular cloning of 25-hydroxyvitamin D-3 24-hydroxylase (Cyp-24) from mouse kidney: its inducibility by vitamin D-3.	Cholecalciferol	31-42	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	59-65	
34504311-4	2022	Interestingly, the increased IgE responses correlated with stimulation of the vitamin D3-metabolizing enzymes CYP27B1 and CYP24A1 in the gut and increased luminal levels of oxidized vitamin D3 metabolites that are not ligands of the vitamin D receptor.	Cholecalciferol	78-88	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	122-129	
16148162-6	2005	Correlating with reduced EAE, the intact, vitamin D(3)-fed female mice had significantly more 1,25-dihydroxyvitamin D(3) and fewer CYP24A1 transcripts, encoding the 1,25-dihydroxyvitamin D(3)-inactivating enzyme, in the spinal cord than the other groups of mice.	Cholecalciferol	42-54	cytochrome P450, family 24, subfamily a, polypeptide 1	Mus musculus	131-138